- Home
- SKX vs PCVX Comparison
SKX vs PCVX Comparison
Compare SKX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- PCVX
- Stock Information
- Founded
- SKX 1992
- PCVX 2013
- Country
- SKX United States
- PCVX United States
- Employees
- SKX N/A
- PCVX N/A
- Industry
- SKX Shoe Manufacturing
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SKX Consumer Discretionary
- PCVX Health Care
- Exchange
- SKX Nasdaq
- PCVX Nasdaq
- Market Cap
- SKX 8.7B
- PCVX 9.6B
- IPO Year
- SKX 1999
- PCVX 2020
- Fundamental
- Price
- SKX $47.63
- PCVX $30.65
- Analyst Decision
- SKX Strong Buy
- PCVX Strong Buy
- Analyst Count
- SKX 12
- PCVX 9
- Target Price
- SKX $74.27
- PCVX $136.50
- AVG Volume (30 Days)
- SKX 3.9M
- PCVX 3.7M
- Earning Date
- SKX 04-24-2025
- PCVX 05-07-2025
- Dividend Yield
- SKX N/A
- PCVX N/A
- EPS Growth
- SKX 19.20
- PCVX N/A
- EPS
- SKX 4.16
- PCVX N/A
- Revenue
- SKX $8,969,351,000.00
- PCVX N/A
- Revenue This Year
- SKX $9.74
- PCVX N/A
- Revenue Next Year
- SKX $8.53
- PCVX N/A
- P/E Ratio
- SKX $11.45
- PCVX N/A
- Revenue Growth
- SKX 12.11
- PCVX N/A
- 52 Week Low
- SKX $44.50
- PCVX $27.66
- 52 Week High
- SKX $78.85
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SKX 36.46
- PCVX 26.64
- Support Level
- SKX $46.16
- PCVX $28.58
- Resistance Level
- SKX $50.68
- PCVX $32.72
- Average True Range (ATR)
- SKX 3.69
- PCVX 3.75
- MACD
- SKX -0.21
- PCVX 0.12
- Stochastic Oscillator
- SKX 20.66
- PCVX 29.09
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.